American College of Cardiology

American College of Cardiology | ACC 2017

The 66th Scientific Session of the American College of Cardiology will bring together cardiovascular professionals from across the globe to meet in Washington, DC, from March 17-19, 2017. The annual conference now features an additional full day of groundbreaking research presentations, debates, and intensive sessions on the most cutting-edge topics in cardiology. Sign up for our daily email-blasts, and check back here during the conference for the full coverage.

Conference Coverages

AFib Sub-Analysis of ARISTOTLE Trial Finds Direct Association Between Digoxin and Risk of Death
AFib Sub-Analysis of ARISTOTLE Trial Finds Direct Association Between Digoxin and Risk of Death VIDEO
Using the database from the 40-country, double-blind phase 3 ARISTOTLE study, which has been around for over 5 years, a sub-analysis was conducted by Renato Lopes, MD, PhD, professor of Medicine at Duke University in Durham, North Carolina and colleagues.
In Case You Missed It: ACC Scientific Sessions 2017 Wrap Up
THe ACC's meeting offered studies likelcc200y to impact clinical practice.
When Do You Bring Up Palliative Care with Patients with Adult Congenital Heart Disease? VIDEO
It’s a discussion that even the most seasoned physicians might struggle with—when is it time to talk end-of-life care? Ami Bhatt, MD, director of the Adult Congenital Heart Disease Program at Massachusetts General Hospital (MGH) explained both sides of the debate for patients with adult congenital heart disease.
Why Is It Necessary to Create a Cardio-Obstetrics Team? VIDEO
Some women may have suffered with cardiovascular problems since birth while others don’t find out until pregnancy unmasks the condition. Doreen DeFaria Yeh, MD, discusses the importance of merging physicians from cardiology and obstetrics.
Direct Oral Anticoagulants vs. Warfarin for Reducing Stroke, Major Bleeding VIDEO
Compared with warfarin, are direct oral anticoagulants (DOACs), including apixaban, dabigatran, and rivaroxaban, better at reducing stroke and major bleeding risks in patients with non-valvular atrial fibrillation? Alpesh Amin, MD, professor of medicine at the University of California, Irvine breaks it down at ACC 2017 in Washington, District of Columbia.
SGLT-2 Inhibitors Reduced All-Cause Mortality Better Than Other Type 2 Diabetes Treatments VIDEO
Steven Zelenkofske, DO, vice president of US Medical Affairs at AstraZeneca, talked with MD Magazine about the CVD-REAL study where researchers examined patients with type 2 diabetes taking the new class of diabetes drug, SGLT-2 inhibitors. Positive outcomes were reported with dapagliflozin, canagliflozin, and empagliflozin.
TAVR Appears to Pose Cognition Risk through Microbleeds
Microbleeds in the brain appear to increase with cardiac procedures:Study.
Heart Damage Common After Any Surgery; Test Could Detect It
Heart damage after non-cardiac surgery is usually missed. A test finds it.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$